Chief financial officer Yemi Okupe told Bloomberg in an interview published Monday that weight-loss drugs comprised about around 20% of last year's sales
Oral GLP-1 formulations are gaining traction, offering patients a needle-free alternative that improves compliance and expands access
A Phase 1, randomised, placebo-controlled, double-blind study was comprised of three parts: a single-ascending dose (SAD
"Many patients do very well on injectable therapies, but there are some inconveniences with long-term injections, such as travel, storage requirements, injection fatigue, or personal preference," Betul Hatipoglu, MD, a professor of medicine at Case Western Reserve University and endocrinologist at University Hospitals Cleveland, told Verywell in an email
When you're asking how long GHK-Cu vial lasts , you're really asking about the longevity of its efficacy